BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 14970278)

  • 21. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.
    Fukuhara H; Kuramochi M; Fukami T; Kasahara K; Furuhata M; Nobukuni T; Maruyama T; Isogai K; Sekiya T; Shuin T; Kitamura T; Reeves RH; Murakami Y
    Jpn J Cancer Res; 2002 Jun; 93(6):605-9. PubMed ID: 12079507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.
    de Wilde J; Wilting SM; Meijer CJ; van de Wiel MA; Ylstra B; Snijders PJ; Steenbergen RD
    Int J Cancer; 2008 Feb; 122(4):877-88. PubMed ID: 17960611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
    Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.
    Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y
    Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
    Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
    Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
    Snijders PJ; van Duin M; Walboomers JM; Steenbergen RD; Risse EK; Helmerhorst TJ; Verheijen RH; Meijer CJ
    Cancer Res; 1998 Sep; 58(17):3812-8. PubMed ID: 9731489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line.
    Steenbergen RD; Kramer D; Meijer CJ; Walboomers JM; Trott DA; Cuthbert AP; Newbold RF; Overkamp WJ; Zdzienicka MZ; Snijders PJ
    J Natl Cancer Inst; 2001 Jun; 93(11):865-72. PubMed ID: 11390536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
    Wilting SM; Steenbergen RD; Tijssen M; van Wieringen WN; Helmerhorst TJ; van Kemenade FJ; Bleeker MC; van de Wiel MA; Carvalho B; Meijer GA; Ylstra B; Meijer CJ; Snijders PJ
    Cancer Res; 2009 Jan; 69(2):647-55. PubMed ID: 19147580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.
    Blanco-Luquin I; Guarch R; Ojer A; Pérez-Janices N; Martín-Sánchez E; Maria-Ruiz S; Monreal-Santesteban I; Blanco-Fernandez L; Pernaut-Leza E; Escors D; Guerrero-Setas D
    Pathol Int; 2015 Sep; 65(9):476-85. PubMed ID: 26222671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
    Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
    Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix.
    Nakagawa S; Yano T; Nakagawa K; Takizawa S; Suzuki Y; Yasugi T; Huibregtse JM; Taketani Y
    Br J Cancer; 2004 Jan; 90(1):194-9. PubMed ID: 14710229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection.
    Sasagawa T; Shimakage M; Nakamura M; Sakaike J; Ishikawa H; Inoue M
    Hum Pathol; 2000 Mar; 31(3):318-26. PubMed ID: 10746674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
    Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
    Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
    Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
    Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions.
    Larson AA; Liao SY; Stanbridge EJ; Cavenee WK; Hampton GM
    Cancer Res; 1997 Oct; 57(19):4171-6. PubMed ID: 9331069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation.
    Allinen M; Peri L; Kujala S; Lahti-Domenici J; Outila K; Karppinen SM; Launonen V; Winqvist R
    Genes Chromosomes Cancer; 2002 Aug; 34(4):384-9. PubMed ID: 12112527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
    Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
    Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
    Mol Carcinog; 2012 Sep; 51(9):723-33. PubMed ID: 21809394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
    Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
    Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.